CatalystFDA/Bio

FDA GIVES EXPEDITED APPROVAL TO NEW GROUNDBREAKING PANCREATIC CANCER DRUG - GUARDIAN

FDA expedited approval signals major regulatory catalyst for pancreatic cancer treatment.

What changed

FDA expedited approval signals major regulatory catalyst for pancreatic cancer treatment.

Why it matters

FDA expedited approval signals major regulatory catalyst for pancreatic cancer treatment. — impact context not separately stored; see What changed.

Sources